IL142002A0 - Insulin preparation for pulmonary delivery containing menthol - Google Patents

Insulin preparation for pulmonary delivery containing menthol

Info

Publication number
IL142002A0
IL142002A0 IL14200299A IL14200299A IL142002A0 IL 142002 A0 IL142002 A0 IL 142002A0 IL 14200299 A IL14200299 A IL 14200299A IL 14200299 A IL14200299 A IL 14200299A IL 142002 A0 IL142002 A0 IL 142002A0
Authority
IL
Israel
Prior art keywords
insulin
pulmonary delivery
formulation
insulin preparation
menthol
Prior art date
Application number
IL14200299A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL142002A0 publication Critical patent/IL142002A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL14200299A 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol IL142002A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801326 1998-10-16
PCT/DK1999/000557 WO2000023099A1 (en) 1998-10-16 1999-10-15 Insulin preparations for pulmonary delivery containing menthol

Publications (1)

Publication Number Publication Date
IL142002A0 true IL142002A0 (en) 2002-03-10

Family

ID=8103609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14200299A IL142002A0 (en) 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol

Country Status (20)

Country Link
EP (1) EP1121145B1 (xx)
JP (1) JP2002527488A (xx)
KR (1) KR20010080132A (xx)
CN (1) CN1323220A (xx)
AT (1) ATE216258T1 (xx)
AU (1) AU758108B2 (xx)
BR (1) BR9914568A (xx)
CA (1) CA2346884A1 (xx)
CZ (1) CZ20011133A3 (xx)
DE (1) DE69901314T2 (xx)
DK (1) DK1121145T3 (xx)
ES (1) ES2177324T3 (xx)
HU (1) HUP0103606A3 (xx)
IL (1) IL142002A0 (xx)
NO (1) NO20011841L (xx)
PL (1) PL347171A1 (xx)
PT (1) PT1121145E (xx)
UA (1) UA67798C2 (xx)
WO (1) WO2000023099A1 (xx)
ZA (1) ZA200102068B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7089053B1 (en) 1999-10-14 2006-08-08 Pola Chemical Industries Inc Compositions for drug administration by electroporation
EP1222931B1 (en) * 1999-10-15 2006-06-07 Pola Chemical Industries Inc. Percutaneous absorption promoters for electroporation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
MX349717B (es) 2008-10-17 2017-08-09 Sanofi Aventis Deutschland Combinación de una insulina y un agonista de glp-1.
HUE037735T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
TR201809460T4 (tr) 2009-11-13 2018-07-23 Sanofi Aventis Deutschland Bir GLP- 1-agonisti, bir insülin ve metiyonin içeren farmasötik bileşim.
SI2611458T1 (sl) 2010-08-30 2017-01-31 Sanofi-Aventis Deutschland Gmbh Uporaba AVE0010 za izdelavo zdravila za zdravljenje sladkorne bolezni tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
SI3229828T1 (sl) 2014-12-12 2023-06-30 Sanofi-Aventis Deutschland Gmbh Formulacija s fiksnim razmerjem inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
ATE369146T1 (de) * 1996-06-20 2007-08-15 Novo Nordisk As Insulinpreparation mit mannitol
JP2001518916A (ja) * 1997-03-20 2001-10-16 ノボ ノルディスク アクティーゼルスカブ 結晶インスリンを含有する肺投与のための治療用粉末調合物

Also Published As

Publication number Publication date
CA2346884A1 (en) 2000-04-27
DE69901314T2 (de) 2002-11-21
WO2000023099A1 (en) 2000-04-27
NO20011841L (no) 2001-06-15
CZ20011133A3 (cs) 2001-08-15
ZA200102068B (en) 2001-10-12
DK1121145T3 (da) 2002-08-12
AU6189099A (en) 2000-05-08
KR20010080132A (ko) 2001-08-22
EP1121145A1 (en) 2001-08-08
EP1121145B1 (en) 2002-04-17
NO20011841D0 (no) 2001-04-10
AU758108B2 (en) 2003-03-13
HUP0103606A2 (hu) 2002-02-28
UA67798C2 (uk) 2004-07-15
PL347171A1 (en) 2002-03-25
HUP0103606A3 (en) 2002-05-28
PT1121145E (pt) 2002-09-30
JP2002527488A (ja) 2002-08-27
DE69901314D1 (de) 2002-05-23
BR9914568A (pt) 2001-07-03
ES2177324T3 (es) 2002-12-01
ATE216258T1 (de) 2002-05-15
CN1323220A (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
IL142002A0 (en) Insulin preparation for pulmonary delivery containing menthol
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
MY115631A (en) Insulin analog formulations
YU56600A (sh) Uređaj za raznošenje aktivnog agensa u pluća pacijenta
DE69920767D1 (de) Stabile konzentrierte Insulin Präparationen zur pulmonaren Verabreichung
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
MY114945A (en) Oral composition
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
ES2180511T3 (es) Formulaciones monodispersas de analogos de insulina acilados hexamericos.
HK1052876A1 (en) Gamma-ifn liquid-droplet aerosol and method
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
AU2615795A (en) Compounds and compositions for administration via oral inhalation or insufflation
DE60103619D1 (de) Pharmazeutische zubereitungen enthaltend alginate
ATE33620T1 (de) Wasserloesliche zusammensetzungen zur herstellung analytischer loesungen.
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
Morris et al. Regional distribution and kinetics of vinyl acetate hydrolysis in the oral cavity of the rat and mouse
GEP20032942B (en) Stabile Pharmaceutical Compositions Comprising Levosimendan and Alginic Acid
EP0813879A3 (en) Drug administration composition for iontophoresis
JPS6470061A (en) Deodorant for livestock and its preparation
PL370860A1 (en) Aromatic herb preparation
JPS5620508A (en) Incense stick
JPS5651979A (en) Preparation of agar medium
SU1665561A1 (ru) Гербицидный состав